Approach to establishing and evaluating clinical relevance of drugs interactions in HIV patients: 2009 update
Aproximación para establecer y evaluar la relevancia clínica de las interacciones medicamentosas en pacientes infectados con virus de la inmunodeficiencia humana: actualización 2009
N.A. Giraldoa,b,d, P. Amarilesa,b,c,
, F.J. Gutiérreza,b,d, M. Monsalvea,b,d, M.J. Fausc,e
Autor para correspondencia
a Grupo de Investigación, Promoción y Prevención Farmacéutica, Universidad de Antioquia, Medellín, Colombia
b Departamento de Farmacia, Facultad de Química Farmacéutica, Universidad de Antioquia, Medellín, Colombia
c Grupo de Investigación en Atención Farmacéutica, Universidad de Granada, Granada, Spain
d Programa de Atención Farmacéutica, Humax Pharmaceutical, Medellín, Colombia
e Departamento de Bioquímica y Biología Molecular, Universidad de Granada, Granada, Spain
Leído
2373
Vecesse ha leído el artículo
964
Total PDF
1409
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 11 | 36 | 7 | 43 |
| 2025 10 | 61 | 24 | 85 |
| 2025 9 | 62 | 20 | 82 |
| 2025 8 | 55 | 45 | 100 |
| 2025 7 | 46 | 33 | 79 |
| 2025 6 | 32 | 20 | 52 |
| 2025 5 | 48 | 23 | 71 |
| 2025 4 | 43 | 27 | 70 |
| 2025 3 | 56 | 25 | 81 |
| 2025 2 | 42 | 31 | 73 |
| 2025 1 | 33 | 25 | 58 |
| 2024 12 | 29 | 16 | 45 |
| 2024 11 | 32 | 22 | 54 |
| 2024 10 | 36 | 15 | 51 |
| 2024 9 | 41 | 15 | 56 |
| 2024 8 | 35 | 16 | 51 |
| 2024 7 | 21 | 16 | 37 |
| 2024 6 | 29 | 13 | 42 |
| 2024 5 | 23 | 14 | 37 |
| 2024 4 | 18 | 13 | 31 |
| 2024 3 | 37 | 18 | 55 |
| 2024 2 | 54 | 15 | 69 |
| 2024 1 | 25 | 15 | 40 |
| 2023 12 | 24 | 14 | 38 |
| 2023 11 | 14 | 14 | 28 |
| 2023 10 | 12 | 14 | 26 |
| 2023 9 | 17 | 26 | 43 |
| 2023 8 | 15 | 8 | 23 |
| 2023 7 | 12 | 10 | 22 |
| 2023 6 | 14 | 16 | 30 |
| 2023 5 | 12 | 18 | 30 |
| 2023 4 | 14 | 12 | 26 |
| 2023 3 | 9 | 11 | 20 |
| 2023 2 | 11 | 13 | 24 |
| 2022 1 | 8 | 3 | 11 |
| 2022 12 | 4 | 8 | 12 |
| 2022 11 | 8 | 4 | 12 |
| 2022 10 | 7 | 5 | 12 |
| 2022 9 | 7 | 12 | 19 |
| 2022 8 | 10 | 12 | 22 |
| 2022 7 | 9 | 6 | 15 |
| 2022 6 | 14 | 14 | 28 |
| 2022 5 | 4 | 5 | 9 |
| 2022 4 | 9 | 10 | 19 |
| 2022 3 | 6 | 6 | 12 |
| 2022 2 | 6 | 4 | 10 |
| 2021 1 | 5 | 7 | 12 |
| 2021 12 | 3 | 9 | 12 |
| 2021 11 | 6 | 8 | 14 |
| 2021 10 | 5 | 10 | 15 |
| 2021 9 | 3 | 6 | 9 |
| 2021 8 | 3 | 3 | 6 |
| 2021 7 | 3 | 7 | 10 |
| 2021 6 | 3 | 3 | 6 |
| 2021 5 | 4 | 7 | 11 |
| 2021 4 | 10 | 5 | 15 |
| 2021 3 | 6 | 5 | 11 |
| 2021 2 | 7 | 8 | 15 |
| 2020 1 | 3 | 11 | 14 |
| 2020 12 | 3 | 2 | 5 |
| 2020 11 | 1 | 5 | 6 |
| 2020 10 | 2 | 1 | 3 |
| 2020 9 | 4 | 7 | 11 |
| 2020 8 | 6 | 4 | 10 |
| 2020 7 | 6 | 11 | 17 |
| 2020 6 | 3 | 4 | 7 |
| 2020 5 | 2 | 3 | 5 |
| 2020 4 | 4 | 1 | 5 |
| 2020 3 | 3 | 3 | 6 |
| 2020 2 | 1 | 4 | 5 |
| 2020 1 | 3 | 4 | 7 |
| 2019 12 | 3 | 10 | 13 |
| 2019 11 | 2 | 2 | 4 |
| 2019 10 | 4 | 2 | 6 |
| 2019 9 | 1 | 7 | 8 |
| 2019 8 | 1 | 0 | 1 |
| 2019 7 | 8 | 9 | 17 |
| 2019 6 | 6 | 6 | 12 |
| 2019 5 | 22 | 11 | 33 |
| 2019 4 | 5 | 14 | 19 |
| 2019 2 | 1 | 6 | 7 |
| 2018 12 | 2 | 8 | 10 |
| 2018 11 | 2 | 2 | 4 |
| 2018 10 | 3 | 11 | 14 |
| 2018 9 | 1 | 3 | 4 |
| 2018 8 | 0 | 1 | 1 |
| 2018 7 | 1 | 4 | 5 |
| 2018 6 | 0 | 1 | 1 |
| 2018 5 | 2 | 1 | 3 |
| 2018 4 | 1 | 1 | 2 |
| 2018 2 | 1 | 1 | 2 |
| 2018 1 | 1 | 0 | 1 |
| 2017 12 | 1 | 2 | 3 |
| 2017 11 | 1 | 1 | 2 |
| 2017 10 | 4 | 0 | 4 |
| 2017 9 | 2 | 0 | 2 |
| 2017 8 | 1 | 1 | 2 |
| 2017 7 | 3 | 0 | 3 |
| 2017 6 | 9 | 2 | 11 |
| 2017 5 | 10 | 1 | 11 |
| 2017 4 | 7 | 1 | 8 |
| 2017 3 | 13 | 2 | 15 |
| 2017 2 | 9 | 0 | 9 |
| 2016 1 | 1 | 1 | 2 |
| 2016 12 | 7 | 0 | 7 |
| 2016 11 | 7 | 1 | 8 |
| 2016 10 | 8 | 0 | 8 |
| 2016 9 | 7 | 1 | 8 |
| 2016 8 | 9 | 0 | 9 |
| 2016 7 | 4 | 0 | 4 |
Mostrar todo
